Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

BUY
$0.08 - $21.0 $400 - $105,000
5,000 Added 7.53%
71,417 $4,000
Q2 2022

Aug 12, 2022

SELL
$0.16 - $0.47 $141 - $416
-886 Reduced 1.32%
66,417 $11,000
Q4 2021

Feb 08, 2022

SELL
$0.56 - $1.71 $82,600 - $252,225
-147,500 Reduced 68.67%
67,303 $38,000
Q3 2021

Nov 02, 2021

SELL
$1.21 - $1.8 $1,535 - $2,284
-1,269 Reduced 0.59%
214,803 $357,000
Q2 2021

Aug 11, 2021

BUY
$1.56 - $1.98 $37,310 - $47,355
23,917 Added 12.45%
216,072 $361,000
Q1 2021

May 14, 2021

SELL
$1.36 - $2.49 $835 - $1,528
-614 Reduced 0.32%
192,155 $325,000
Q4 2020

Feb 12, 2021

BUY
$0.75 - $2.76 $1,026 - $3,778
1,369 Added 0.72%
192,769 $307,000
Q3 2020

Nov 04, 2020

SELL
$0.61 - $1.17 $1,830 - $3,510
-3,000 Reduced 1.54%
191,400 $183,000
Q2 2020

Jul 28, 2020

SELL
$0.47 - $0.72 $2,350 - $3,600
-5,000 Reduced 2.51%
194,400 $124,000
Q1 2020

Apr 21, 2020

BUY
$0.36 - $0.74 $324 - $666
900 Added 0.45%
199,400 $83,000
Q4 2019

Feb 12, 2020

BUY
$0.35 - $0.58 $2,625 - $4,350
7,500 Added 3.93%
198,500 $116,000
Q3 2019

Nov 07, 2019

BUY
$0.38 - $0.52 $19,000 - $26,000
50,000 Added 35.46%
191,000 $96,000
Q2 2019

Aug 06, 2019

BUY
$0.39 - $0.7 $5,850 - $10,500
15,000 Added 11.9%
141,000 $55,000
Q1 2019

May 06, 2019

BUY
$0.43 - $0.68 $47,300 - $74,800
110,000 Added 687.5%
126,000 $71,000
Q4 2018

Feb 11, 2019

SELL
$0.39 - $0.7 $24,308 - $43,630
-62,329 Reduced 79.57%
16,000 $6,000
Q3 2018

Nov 14, 2018

BUY
$0.44 - $3.02 $7,367 - $50,569
16,745 Added 27.19%
78,329 $40,000
Q2 2018

Aug 14, 2018

BUY
$1.66 - $3.82 $4,150 - $9,550
2,500 Added 4.23%
61,584 $135,000
Q1 2018

May 14, 2018

BUY
$2.16 - $3.48 $54,980 - $88,579
25,454 Added 75.69%
59,084 $201,000
Q4 2017

Feb 14, 2018

BUY
$0.68 - $4.19 $22,868 - $140,909
33,630 New
33,630 $137,000
Q3 2017

Nov 13, 2017

SELL
$0.38 - $0.66 $6,080 - $10,560
-16,000 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
16,000
16,000 $8,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.